Research programme: small molecule therapeutics: Hexagon Bio
Latest Information Update: 28 Sep 2020
At a glance
- Originator Hexagon Bio
- Class Anti-infectives; Antineoplastics; Neuroprotectants; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Cancer; Cardiovascular disorders; Immunological disorders; Infections; Metabolic disorders; Neurological disorders